R-Pharm Group is a key player in the Russian pharmaceutical market, established in 2001 by Alexey Repik. In 2017, Mitsui & Co., Ltd., a Japanese corporation, acquired 10% of JSC R-Pharm's shares. The company's mission is to enhance the accessibility of cutting-edge medicines for patients in Russia and globally. With over 3,000 skilled professionals, R-Pharm operates across the Russian Federation, CIS member states, USA, Germany, Japan, and various other nations.
Products & Services
Sodium Polydeoxyribonucleotide
Sites
Br Pharm
Country
South KoreaCity
Weonju